Table 3 Percentages of patients showing positive immunohistochemical reactions to p-ELK-1, ATF-2 [31], p50 and p65 [5] in normal prostate (NP), benign prostatic hyperplasia (BPH) and prostatic carcinoma (PC) and average optical densities of immunostaining in positive patients.

Normal (20)

100

2.41 ± 0.9^a

100

3.34 ± 0.83^a

60

7.88 ± 2.4*

0

14.28

9.42 ± 5.13*

100

18.6 ± 1.72^#

71.4

9.08 ± 3.23*

82.85

10.52 ± 2.56^b

45.71

5.25 ± 2.16^a

100

3.22 ± 0.7^a

100

4.32 ± 1.09*

58.3

15.32 ± 2.00^#

0

60

17.35 ± 1.45^#

53.3

13.35 ± 1.78^#

86.6

27.51 ± 2.79^§

93.3

30.17 ± 3.08^#

40

18.27 ± 2.31^c

26.6

12.31 ± 4.21^b

26.6

28.76 ± 3.31^a

13.3

29.77 ± 2.13^a

66.6

19.62 ± 5.64^#

61.9

12.68 ± 3.28^#

80.9

28.01 ± 2.25^§

100

23.8 ± 2.93^§

42.85

18.65 ± 3.4^c

23.8

10.58 ± 1.2^b

30.1

32.08 ± 2.96^a

19

28.34 ± 2.04^a

72.54

17.75 ± 4.54^#

68.62

11.75 ± 3.45^#

94.1

29.17 ± 1.22^§

92.1

29.09 ± 1.90^#

37.25

17.23 ± 3.56^c

19.6

9.56 ± 3.87^b

41.2

33.82 ± 4.07^a

45.1

34.91 ± 4.32^b

85.71

19.76 ± 4.78^#

76.19

12.98 ± 5.11^#

100

39.37 ± 4.15^¥

80.9

36.71 ± 2.18^¥

33.3

18.76 ± 3.87^c

14.28

13.43 ± 3.56^b

47.6

41.26 ± 2.31^b

71.4

46.56 ± 1.20^c